Andres I Vecino-Ortiz1, Juliana Villanueva Congote2, Silvana Zapata Bedoya3, Zulma M Cucunuba4,5. 1. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America. 2. Research Office, San Ignacio University Hospital, Bogota, Colombia. 3. Planning Department, Government of the Department of Antioquia in Colombia, Medellín, Colombia. 4. MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom. 5. Department of Clinical Epidemiology and Biostatistics, School of Medicine, Pontificia Universidad Javeriana, Bogota, Colombia.
Abstract
BACKGROUND: Contact tracing is a crucial part of the public health surveillance toolkit. However, it is labor-intensive and costly to carry it out. Some countries have faced challenges implementing contact tracing, and no impact evaluations using empirical data have assessed its impact on COVID-19 mortality. This study assesses the impact of contact tracing in a middle-income country, providing data to support the expansion and optimization of contact tracing strategies to improve infection control. METHODS: We obtained publicly available data on all confirmed COVID-19 cases in Colombia between March 2 and June 16, 2020. (N = 54,931 cases over 135 days of observation). As suggested by WHO guidelines, we proxied contact tracing performance as the proportion of cases identified through contact tracing out of all cases identified. We calculated the daily proportion of cases identified through contact tracing across 37 geographical units (32 departments and five districts). Further, we used a sequential log-log fixed-effects model to estimate the 21-days, 28-days, 42-days, and 56-days lagged impact of the proportion of cases identified through contact tracing on daily COVID-19 mortality. Both the proportion of cases identified through contact tracing and the daily number of COVID-19 deaths are smoothed using 7-day moving averages. Models control for the prevalence of active cases, second-degree polynomials, and mobility indices. Robustness checks to include supply-side variables were performed. RESULTS: We found that a 10 percent increase in the proportion of cases identified through contact tracing is related to COVID-19 mortality reductions between 0.8% and 3.4%. Our models explain between 47%-70% of the variance in mortality. Results are robust to changes of specification and inclusion of supply-side variables. CONCLUSION: Contact tracing is instrumental in containing infectious diseases. Its prioritization as a surveillance strategy will substantially impact reducing deaths while minimizing the impact on the fragile economic systems of lower and middle-income countries. This study provides lessons for other LMIC.
BACKGROUND: Contact tracing is a crucial part of the public health surveillance toolkit. However, it is labor-intensive and costly to carry it out. Some countries have faced challenges implementing contact tracing, and no impact evaluations using empirical data have assessed its impact on COVID-19 mortality. This study assesses the impact of contact tracing in a middle-income country, providing data to support the expansion and optimization of contact tracing strategies to improve infection control. METHODS: We obtained publicly available data on all confirmed COVID-19 cases in Colombia between March 2 and June 16, 2020. (N = 54,931 cases over 135 days of observation). As suggested by WHO guidelines, we proxied contact tracing performance as the proportion of cases identified through contact tracing out of all cases identified. We calculated the daily proportion of cases identified through contact tracing across 37 geographical units (32 departments and five districts). Further, we used a sequential log-log fixed-effects model to estimate the 21-days, 28-days, 42-days, and 56-days lagged impact of the proportion of cases identified through contact tracing on daily COVID-19 mortality. Both the proportion of cases identified through contact tracing and the daily number of COVID-19 deaths are smoothed using 7-day moving averages. Models control for the prevalence of active cases, second-degree polynomials, and mobility indices. Robustness checks to include supply-side variables were performed. RESULTS: We found that a 10 percent increase in the proportion of cases identified through contact tracing is related to COVID-19 mortality reductions between 0.8% and 3.4%. Our models explain between 47%-70% of the variance in mortality. Results are robust to changes of specification and inclusion of supply-side variables. CONCLUSION: Contact tracing is instrumental in containing infectious diseases. Its prioritization as a surveillance strategy will substantially impact reducing deaths while minimizing the impact on the fragile economic systems of lower and middle-income countries. This study provides lessons for other LMIC.
Authors: Adam J Kucharski; Petra Klepac; Andrew J K Conlan; Stephen M Kissler; Maria L Tang; Hannah Fry; Julia R Gog; W John Edmunds Journal: Lancet Infect Dis Date: 2020-06-16 Impact factor: 25.071
Authors: Mirjam E Kretzschmar; Ganna Rozhnova; Martin C J Bootsma; Michiel van Boven; Janneke H H M van de Wijgert; Marc J M Bonten Journal: Lancet Public Health Date: 2020-07-16
Authors: Billy J Quilty; Samuel Clifford; Joel Hellewell; Timothy W Russell; Adam J Kucharski; Stefan Flasche; W John Edmunds Journal: Lancet Public Health Date: 2021-01-21
Authors: Patrick G T Walker; Charles Whittaker; Oliver J Watson; Marc Baguelin; Peter Winskill; Arran Hamlet; Bimandra A Djafaara; Zulma Cucunubá; Daniela Olivera Mesa; Will Green; Hayley Thompson; Shevanthi Nayagam; Kylie E C Ainslie; Sangeeta Bhatia; Samir Bhatt; Adhiratha Boonyasiri; Olivia Boyd; Nicholas F Brazeau; Lorenzo Cattarino; Gina Cuomo-Dannenburg; Amy Dighe; Christl A Donnelly; Ilaria Dorigatti; Sabine L van Elsland; Rich FitzJohn; Han Fu; Katy A M Gaythorpe; Lily Geidelberg; Nicholas Grassly; David Haw; Sarah Hayes; Wes Hinsley; Natsuko Imai; David Jorgensen; Edward Knock; Daniel Laydon; Swapnil Mishra; Gemma Nedjati-Gilani; Lucy C Okell; H Juliette Unwin; Robert Verity; Michaela Vollmer; Caroline E Walters; Haowei Wang; Yuanrong Wang; Xiaoyue Xi; David G Lalloo; Neil M Ferguson; Azra C Ghani Journal: Science Date: 2020-06-12 Impact factor: 47.728
Authors: Francisco Garcia-Cardenas; Fernando Peñaloza; Jennifer Bertin-Montoya; Rafael Valdéz-Vázquez; Alba Franco; Ricardo Cortés; Emmanuel Frias-Jimenez; Alberto Cedro-Tanda; Alfredo Mendoza-Vargas; Juan Pablo Reyes-Grajeda; Alfredo Hidalgo-Miranda; Luis A Herrera Journal: Pathogens Date: 2022-05-30
Authors: Mary F Reyes-Vega; M Gabriela Soto-Cabezas; Fany Cárdenas; Kevin S Martel; Andree Valle; Juan Valverde; Margot Vidal-Anzardo; María Elena Falcón; César V Munayco Journal: EClinicalMedicine Date: 2021-03-30
Authors: Yenny Guzmán Ruiz; Andres I Vecino-Ortiz; Nicolás Guzman-Tordecilla; Rolando Enrique Peñaloza-Quintero; Julián A Fernández-Niño; Maylen Rojas-Botero; Fernando Ruiz Gomez; Sean D Sullivan; Antonio J Trujillo Journal: Lancet Reg Health Am Date: 2021-11-01
Authors: Shamsa Zafar; Carmen Sant Fruchtman; Muhammad Bilal Khalid; Zaeem Zia; Fawad Khalid Khan; Shahid Iqbal; Daniel Cobos Muñoz Journal: Front Public Health Date: 2022-09-13